July 12, 2024

Medical Marijuana Market Size to Reach USD 120.15 Bn by 2033

The global medical marijuana market size is expected to increase USD 120.15 billion by 2033 from USD 16.68 billion in 2023 with a CAGR of 21.83% between 2024 to 2033.

Key Points

  • The North America medical marijuana market size was evaluated at USD 12.84 billion in 2023 and is expected to attain around USD 93.12 billion by 2033, poised to grow at a CAGR of 21.91% between 2024 and 2033.
  • North America dominated the market with the largest share in 2023.
  • Asia Pacific is expected to register the fastest growth during the forecast period.
  • By type, the oils segment dominated the market in 2023.
  • By application, the chronic pain segment registered the largest shares in 2023.
  • By application, the amyotrophic lateral sclerosis (ALS) segment is expected to register the fastest growth during the forecast period.

Medical Marijuana Market Size 2024 to 2033

The medical marijuana market has experienced significant growth in recent years, driven by increasing acceptance of cannabis for therapeutic purposes. Medical marijuana refers to the use of cannabis and its cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), to treat various medical conditions. This market encompasses pharmaceuticals derived from marijuana plants, as well as products such as oils, tinctures, and edibles that are used for medicinal purposes.

Get a Sample: https://www.precedenceresearch.com/sample/4447

Growth Factors

Several factors contribute to the growth of the medical marijuana market. Firstly, changing attitudes towards cannabis, with an increasing number of countries and states legalizing its medical use, have expanded the market significantly. The growing awareness among healthcare professionals and patients about the therapeutic benefits of marijuana for conditions like chronic pain, epilepsy, and multiple sclerosis has also fueled demand. Moreover, ongoing research into the efficacy and safety of medical marijuana continues to provide evidence supporting its medical use, further boosting market growth.

Regional Insights

The regulatory landscape significantly influences the regional dynamics of the medical marijuana market. In North America, countries like the United States and Canada have legalized medical marijuana at varying levels, leading to a mature market with established infrastructure and regulatory frameworks. In Europe, countries such as Germany and the Netherlands have legalized medical cannabis, although regulations vary widely across the region. Meanwhile, in Asia-Pacific and Latin America, regulatory environments are evolving, with some countries beginning to explore or implement medical cannabis programs.

Medical Marijuana Market Scope

Report CoverageDetails
Market Size in 2023USD 16.68 Billion
Market Size in 2024USD 20.32 Billion
Market Size by 2033USD 120.15 Billion
Market Growth Rate From 2024 to 2033CAGR of 21.83%
Largest MarketNorth America
Base Year2023
Forecast Period2024 to 2033
Segments CoveredType, Application, and Regions
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Medical Marijuana Market Dynamics


Several key drivers propel the growth of the medical marijuana market. Firstly, the increasing prevalence of chronic diseases such as cancer and arthritis, for which medical marijuana offers pain relief and symptom management, drives demand. Additionally, the growing elderly population, who are more likely to suffer from chronic conditions that could benefit from cannabis treatment, contributes to market expansion. Furthermore, the emergence of new delivery methods and product formulations, including oils, capsules, and patches, enhances patient accessibility and acceptance of medical marijuana.


The medical marijuana market presents numerous opportunities for growth and innovation. Continued research into the therapeutic potential of cannabinoids and other compounds found in cannabis could lead to the development of novel pharmaceuticals and treatment options. Expansion into new geographic markets as legalization progresses globally provides opportunities for market penetration and revenue growth. Moreover, partnerships between cannabis producers and pharmaceutical companies to develop standardized, clinically tested products could further legitimize medical marijuana and expand its acceptance among healthcare professionals.


Despite its growth prospects, the medical marijuana market faces several challenges. Regulatory hurdles, varying from strict regulations in some regions to outright prohibition in others, create barriers to market entry and expansion. Concerns over the safety and efficacy of medical marijuana, particularly regarding long-term use and potential adverse effects, continue to be debated among healthcare professionals and regulatory authorities. Additionally, the stigma associated with cannabis use, both recreationally and medicinally, remains a challenge, impacting patient and physician attitudes towards its adoption as a medical treatment.

Read Also: Laparoscopic Instruments Market Size to Surpass USD 45.06 Bn by 2033

Medical Marijuana Market Companies

  • Canopy Growth Corporation
  • Cannabis Sativa Inc
  • GW Pharmaceuticals Plc
  • CanniMed Ltd
  • Pfizer Inc
  • Medical Marijuana Inc
  • GBSciences Inc
  • MediPharm Labs
  • Emerald Health Therapeutics Inc
  • Aphria
  • Tilray
  • Aurora Cannabis
  • Maricann Group, Inc.
  • Tikun Olam, Ltd.
  • MedReleaf. Corp.
  • GW Pharmaceuticals plc.
  • Medical Marijuana, Inc.

Recent Developments:

  • In November 2023, Tilray acquired MedMen Enterprises to increase the marijuana medicine network all over North America.
  • In 2023, Curaleaf announced its medicine sales expansion in Germany. The company aims to provide high-quality marijuana medicines all over Europe.
  • In 2023, Metrc collaborated with the state of Missouri to boost the regulation of the adult-use cannabis market.
  • In 2023, Cannabis Corporation announced their new medical marijuana products designed especially for senior citizens. The newly introduced medicines are designed for easy use and contain low THC, making them easily accessible to adults.

Segments Covered in the Report

By Type

  • Oils
  • Capsules
  • Others

By Application

  • Chronic Pain
  • Amyotrophic Lateral Sclerosis (ALS)
  • Anxiety and Depression

By Geography

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East & Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/